Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Gossamer Bio (GOSS) Net Margin: 2022-2025

Historic Net Margin for Gossamer Bio (GOSS) over the last 4 years, with Sep 2025 value amounting to -362.73%.

  • Gossamer Bio's Net Margin fell 3780.00% to -362.73% in Q3 2025 from the same period last year, while for Sep 2025 it was -783.79%, marking a year-over-year decrease of 61642.00%. This contributed to the annual value of -62.32% for FY2024, which is 139322.00% down from last year.
  • Per Gossamer Bio's latest filing, its Net Margin stood at -362.73% for Q3 2025, which was down 13.74% from -318.90% recorded in Q2 2025.
  • In the past 5 years, Gossamer Bio's Net Margin ranged from a high of 1,698.73% in Q3 2022 and a low of -397.03% during Q1 2025.
  • For the 3-year period, Gossamer Bio's Net Margin averaged around 525.33%, with its median value being 225.89% (2024).
  • Data for Gossamer Bio's Net Margin shows a maximum YoY plummeted of 182,700bps (in 2025) over the last 5 years.
  • Quarterly analysis of 4 years shows Gossamer Bio's Net Margin stood at 1,655.19% in 2022, then slumped by 16,868bps to 1,486.51% in 2023, then plummeted by 126,062bps to 225.89% in 2024, then plummeted by 3,780bps to -362.73% in 2025.
  • Its Net Margin stands at -362.73% for Q3 2025, versus -318.90% for Q2 2025 and -397.03% for Q1 2025.